161 related articles for article (PubMed ID: 26536195)
1. Clinicopathological and Survival Analysis of Japanese Patients with Resected Non-Small-Cell Lung Cancer Harboring NKX2-1, SETDB1, MET, HER2, SOX2, FGFR1, or PIK3CA Gene Amplification.
Inoue Y; Matsuura S; Kurabe N; Kahyo T; Mori H; Kawase A; Karayama M; Inui N; Funai K; Shinmura K; Suda T; Sugimura H
J Thorac Oncol; 2015 Nov; 10(11):1590-600. PubMed ID: 26536195
[TBL] [Abstract][Full Text] [Related]
2. Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease.
Toschi L; Finocchiaro G; Nguyen TT; Skokan MC; Giordano L; Gianoncelli L; Perrino M; Siracusano L; Di Tommaso L; Infante M; Alloisio M; Roncalli M; Scorsetti M; Jänne PA; Santoro A; Varella-Garcia M
PLoS One; 2014; 9(4):e95303. PubMed ID: 24736592
[TBL] [Abstract][Full Text] [Related]
3. High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer.
Go H; Jeon YK; Park HJ; Sung SW; Seo JW; Chung DH
J Thorac Oncol; 2010 Mar; 5(3):305-13. PubMed ID: 20107422
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer.
Tran TN; Selinger CI; Kohonen-Corish MRJ; McCaughan BC; Kennedy CW; O'Toole SA; Cooper WA
Lung Cancer; 2013 Sep; 81(3):462-467. PubMed ID: 23806793
[TBL] [Abstract][Full Text] [Related]
5. EGFR and TTF-1 gene amplification in surgically resected lung adenocarcinomas: clinicopathologic significance and effect on response to EGFR-tyrosine kinase inhibitors in recurred cases.
Lee JS; Kim HR; Lee CY; Shin M; Shim HS
Ann Surg Oncol; 2013 Sep; 20(9):3015-22. PubMed ID: 23525704
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.
Cihoric N; Savic S; Schneider S; Ackermann I; Bichsel-Naef M; Schmid RA; Lardinois D; Gugger M; Bubendorf L; Zlobec I; Tapia C
Br J Cancer; 2014 Jun; 110(12):2914-22. PubMed ID: 24853178
[TBL] [Abstract][Full Text] [Related]
7. HER2 gene mutations in non-small cell lung carcinomas: concurrence with Her2 gene amplification and Her2 protein expression and phosphorylation.
Suzuki M; Shiraishi K; Yoshida A; Shimada Y; Suzuki K; Asamura H; Furuta K; Kohno T; Tsuta K
Lung Cancer; 2015 Jan; 87(1):14-22. PubMed ID: 25468202
[TBL] [Abstract][Full Text] [Related]
8. Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer.
Tran TN; Selinger CI; Yu B; Ng CC; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA
J Clin Pathol; 2014 Nov; 67(11):985-91. PubMed ID: 25118293
[TBL] [Abstract][Full Text] [Related]
9. The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.
Park JS; Lee JS; Kim EY; Jung JY; Kim SK; Chang J; Kim DJ; Lee CY; Jung I; Kim JH; Kim HR; Moon YW; Kim HS; Cho BC; Shim HS
Lung Cancer; 2015 Jun; 88(3):325-31. PubMed ID: 25819384
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.
Kim HR; Kim DJ; Kang DR; Lee JG; Lim SM; Lee CY; Rha SY; Bae MK; Lee YJ; Kim SH; Ha SJ; Soo RA; Chung KY; Kim JH; Lee JH; Shim HS; Cho BC
J Clin Oncol; 2013 Feb; 31(6):731-7. PubMed ID: 23182986
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patients.
Al-Saad S; Al-Shibli K; Donnem T; Andersen S; Bremnes RM; Busund LT
J Thorac Oncol; 2010 Oct; 5(10):1536-43. PubMed ID: 20802349
[TBL] [Abstract][Full Text] [Related]
12. FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer.
Seo AN; Jin Y; Lee HJ; Sun PL; Kim H; Jheon S; Kim K; Lee CT; Chung JH
Virchows Arch; 2014 Nov; 465(5):547-58. PubMed ID: 25086725
[TBL] [Abstract][Full Text] [Related]
13. PIK3CA gene amplification in Japanese non-small cell lung cancer.
Kawano O; Sasaki H; Okuda K; Yukiue H; Yokoyama T; Yano M; Fujii Y
Lung Cancer; 2007 Oct; 58(1):159-60. PubMed ID: 17681398
[TBL] [Abstract][Full Text] [Related]
14. p95HER2 truncated form in resected non-small cell lung cancer.
Cappuzzo F; Cho YG; Sacconi A; Alì G; Siclari O; Incarbone M; Destro A; Terracciano L; Fontanini G; Marchetti A; Roncalli M; Varella-Garcia M
J Thorac Oncol; 2012 Mar; 7(3):520-7. PubMed ID: 22307009
[TBL] [Abstract][Full Text] [Related]
15. Opposite roles of FOXA1 and NKX2-1 in lung cancer progression.
Deutsch L; Wrage M; Koops S; Glatzel M; Uzunoglu FG; Kutup A; Hinsch A; Sauter G; Izbicki JR; Pantel K; Wikman H
Genes Chromosomes Cancer; 2012 Jun; 51(6):618-29. PubMed ID: 22383183
[TBL] [Abstract][Full Text] [Related]
16. Genomic Copy Number Signatures Uncovered a Genetically Distinct Group from Adenocarcinoma and Squamous Cell Carcinoma in Non-Small Cell Lung Cancer.
Lee E; Moon JW; Wang X; Kim C; Li S; Shin BK; Jung W; Kim HK; Kim HK; Lee JY
Hum Pathol; 2015 Aug; 46(8):1111-20. PubMed ID: 26003479
[TBL] [Abstract][Full Text] [Related]
17. Lack of prognostic implications of HER-2/neu abnormalities in 345 stage I non-small cell carcinomas (NSCLC) and 207 stage I-III neuroendocrine tumours (NET) of the lung.
Pelosi G; Del Curto B; Dell'Orto P; Pasini F; Veronesi G; Spaggiari L; Maisonneuve P; Iannucci A; Terzi A; Lonardoni A; Viale G
Int J Cancer; 2005 Jan; 113(1):101-8. PubMed ID: 15386424
[TBL] [Abstract][Full Text] [Related]
18. Genetic alteration profiling of patients with resected squamous cell lung carcinomas.
Tao D; Han X; Zhang N; Lin D; Wu D; Zhu X; Song W; Shi Y
Oncotarget; 2016 Jun; 7(24):36590-36601. PubMed ID: 27145277
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor 1 amplification in non-small cell lung cancer by quantitative real-time PCR.
Gadgeel SM; Chen W; Cote ML; Bollig-Fischer A; Land S; Schwartz AG; Bepler G
PLoS One; 2013; 8(11):e79820. PubMed ID: 24255716
[TBL] [Abstract][Full Text] [Related]
20. Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models.
Zhang J; Zhang L; Su X; Li M; Xie L; Malchers F; Fan S; Yin X; Xu Y; Liu K; Dong Z; Zhu G; Qian Z; Tang L; Schöttle J; Zhan P; Ji Q; Kilgour E; Smith PD; Brooks AN; Thomas RK; Gavine PR
Clin Cancer Res; 2012 Dec; 18(24):6658-67. PubMed ID: 23082000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]